Meet the dedicated team developing research-guided botanical formulations for general wellness support
Our Founder has researched phytochemicals, the endocannabinoid system, and the vast potential of cannabinoids since the mid 90's. By 2016 he completed development of a product to aid his grandmother in her battle with shingles. This humble beginning soon evolved into a complete groundbreaking system of immune modulation.
When the world was gripped by the pandemic in early 2020, he recognized the connection between his research and COVID-19, prompting him to theorize the application of his system of immune modulation.
In July 2020, he contracted COVID-19 himself. He used his proof of concept, successfully reducing his own COVID-19 symptoms. Fueled by a desire to help others, he began assisting friends and family, continually refining, and enhancing his formulation. By August 2020, he filed his first patent for his novel system of immune modulation, a significant step towards transforming the landscape of healthcare.
Jai Verma is a visionary global leader with more than two decades of experience across healthcare, biotechnology, blockchain, mining, real estate, and agriculture. As Chief Executive Officer of EPI1 Immunotech Inc., he directs the company's strategic growth, partnerships, and commercialization efforts—advancing biotechnology innovation and expanding EPI1's position as a global force in immunotherapeutic research and production.
In addition to his role at EPI1, Jai serves as Chairman and CEO of Protecti Global Holdings Ltd., a diversified investment platform that drives innovation across multiple industries and geographies. Before founding Protecti Global Holdings, Jai made significant contributions to the healthcare sector as Global CEO of Government Solutions at Cigna Corporation, a Fortune 12 healthcare powerhouse.
Earlier in his career, Jai held senior roles with several Fortune 500 and multinational firms, including Aetna (a CVS Health Company), UnitedHealth Group, Marsh & McLennan, Allianz AG, and the Hinduja Group. He completed executive programs at The Wharton School and continues to serve as a board member and advisor for ventures such as 144 Ventures, Gochain, Wonder Hill Studios, VM Petro, and Glen Cove Villa.
René Contreras is a global operations and commercial strategy executive with more than 15 years of leadership experience spanning pharmaceutical manufacturing, healthcare distribution, and supply chain transformation. He is recognized for building scalable operational frameworks in highly regulated industries and for driving measurable performance across manufacturing, supplier management, and commercialization readiness in global markets.
As President of EPI1 Immunotech Inc., René leads the company's manufacturing strategy, commercial supply infrastructure, and global partnerships. His focus includes advancing biotechnology production capabilities, optimizing vendor relationships, and ensuring operational excellence to support EPI1's mission of delivering innovative immunotherapeutic solutions.
Before joining EPI1, René served in senior leadership roles at McKesson Corporation, one of the world's largest healthcare and pharmaceutical distribution companies. During his tenure, he directed sourcing, commercial strategy, and supplier partnerships representing over $100 billion in annual portfolio value, creating pricing frameworks and value-based contract structures that improved profitability by up to 30 percent.
Dr. Sambhu Choudhury is a distinguished orthopedic surgeon and medical innovator with more than 20 years of experience spanning pediatric and adult reconstruction, complex trauma, and joint surgery. As Chief Medical Officer at EPI1 Immunotech Inc., he leads clinical strategy and evidence generation, guiding product development, safety oversight, and physician partnerships to advance science-driven immunotherapeutic solutions.
Trained at the Mayo Clinic and fellowship-trained at Cincinnati Children's Hospital, Dr. Choudhury combines rigorous clinical discipline with an educator's mindset. He serves as an attending orthopedic surgeon with Mercy Health Physicians and has held long-standing faculty roles at the Frank Noyes Institute, with teaching appointments at The Jewish Hospital and the University of Cincinnati College of Medicine.
Beyond the operating room, Dr. Choudhury is an accomplished inventor and entrepreneur with over 15 U.S. patents across surgical devices, orthopedic implants, and wearable medical technologies. He has founded and led multiple ventures and has served in senior leadership roles such as Chief Medical Officer of SNAPBACK Corporation, consistently translating unmet clinical needs into practical solutions.
Interested in learning more about our leadership team or exploring partnership opportunities?